ACTIVE PHARMACEUTICAL INGREDIENTS …

GUIDANCE ON ASPECTS OF CLEANING ... - …

confidential 1 revision september 2016 active pharmaceutical ingredients committee (apic) guidance on aspects of cleaning validation in …

  Pharmaceutical, Active, Ingredients, Committees, Apic, Active pharmaceutical ingredients committee

Guidance on aspects of cleaning validation in active ...

Cleaning Validation Guidance 3 1.0 Foreword This document has been prepared by the cleaning validation task force within the active …

  Validation, Guidance, Validation guidance

GUIDELINE for QUALIFICATION & MANAGEMENT …

active pharmaceutical ingredients committee (apic) guideline for qualification & management of contract quality control laboratories 10 january 2012

  Management, Contract

Quality Management System - apic.cefic.org

Quality Management System (QMS) for Active Pharmaceutical Ingredients (API) Manufacturers integrating GMP (ICH Q7a) into ISO (9001: 2000) September 2005

  System, Pharmaceutical, Management, Quality, Quality management system

Registered Starting Material Auditing Guide - …

AIDE MEMOIRE FOR REGISTERED STARTING MATERIAL AUDITS 1) APIC Guide for Auditing Registered Starting Material Manufacturers * tbi = to be implemented Page 2 / 23 ** Procedure, SOP, OI, memo, notes (personal), Q-manual

  Auditing

Guidance on Handling of Insoluble Matter and …

APIC Guidance on Insoluble Matter and Foreign Particles in APIs Page 3 of 19 Table of contents 1. Acknowledgements 2. Introduction and Purpose

Quality Agreement for Laboratories Guideline Templates

A Quality Agreement under the scope of this guideline is a legally binding agreement that is mutually negotiated and concluded between (the Quality Departments of) the service requestor and the Quality responsible at the service providing laboratory.

  Laboratory, Agreement

ACTIVE PHARMACEUTICAL INGREDIENTS COMMITTEE …

- Stefaan Van De Velde, Ajinomoto Bio-Pharma Services, Belgium A revision of the guidance document was done in 2016 to bring it in line with the European Medicines Agency Guidance on use of Health Based data on setting health-based exposure limits for determining safe threshold values for the cleaning1. The main changes were

  Pharmaceutical, Active, Ingredients, Committees, Active pharmaceutical ingredients committee, Pharma

“How to do” Document

The explanatory notes in this guide are the views of The Active Pharmaceutical Ingredients Commit- tee (APIC) and not necessarily those of the European Commission or WHO. This document does not intend to provide an exhaustive list of how to comply with the require-

  Notes, Pharmaceutical, Document, Explanatory notes, Explanatory, How to do document

Practical risk-based guide for managing data integrity

Assign GxP data to a specific category based on a . severity assessment (refer to section 4.1) Create a . profile. of each . system. based on the way GxP data is handled by that system (e.g. data generation, storage, processing, transfer or a combination thereof) and assign a category to the system based on its profile; (refer to section 4.2)

  Based, Managing

Guideline on the specifications for provision of an ...

Guideline on specification for veterinary e-submissions Page 3 of 18 Introduction This Guidance Document is intended to assist applicants and regulators with submissions of …

  Guidelines

Guideline on Active Substance Master File Procedure

The main objective of the Active Substance Master File (ASMF ) procedure, formerly known as the European Drug Master File (EDMF) procedure, is to allow valuable confidential intellectual property or

  Guidelines, Active, Life, Procedures, Master, Substance, Guideline on active substance master file procedure, Active substance master file, Master file

CMDv/BPG/012 BEST PRACTICE GUIDE for Informed …

3. legal framework 4. references and related documents 5. general 6. description of the procedure annex 1: template for letter of access for an application under

  Procedures

Appendix 8 Data Requirements for New Medicine …

control of starting materials, reagents, catalysts, solvents and any isolated intermediates, as well as any subsequent processing (eg, milling) of the bulk substance.

  Requirements, Medicine, Substance, Requirements for new medicine

STABILITY TESTING OF ACTIVE SUBSTANCES AND …

Working document QAS/06.179 page 2 REGIONAL GUIDELINE FOR THE WHO EASTERN MEDITERRANEAN REGION STABILITY TESTING OF ACTIVE SUBSTANCES AND PHARMACEUTICAL PRODUCTS DRAFT 2.0 19 April 2006 This guideline has been developed during the WHO EMRO Consultation on Regional

  Guidelines, Product, Pharmaceutical, Testing, Active, Stability, Substance, Stability testing of active substances and pharmaceutical products, Stability testing of active substances

Forced degradation studies – comparison between …

Page 1 1. Introduction and scope Forced degradation is an exposure of the drug substance or drug product to different stress conditions (more severe than accelerated conditions) [1] which results in relevant

  Substance